After opening up about living with alopecia during the second season of Bravo’s “Summer House: Martha’s Vineyard,” Jordan ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

New long-term safety and efficacy data of investigational roflumilast cream 0.15% in mild to moderate atopic dermatitis will be presented in an ...

Soterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its ...

The positive top-line data from the Phase 2 study in treating alopecia areata (AA), an autoimmune condition resulting in hair loss, significantly influenced his perspective. Notably, the study ...

A study using a large Korean health database found that people with a rare hair loss disorder called primary cicatricial ...

Soterios Pharma is eyeing phase 3 after a 1% dose of the company's alopecia areata cream improved severity of the condition, ...

Investigators found that the use of oral contraceptives (OCs) may be associated with an increased risk for frontal fibrosing ...

Kelsey McEwen is getting candid about her "so-called imperfection." On Sunday, the "Your Morning" meteorologist took to ...

Children with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with dupilumab demonstrated ...

CHICAGO -- Germline variations did not predict the risk of taxane-induced peripheral neuropathy (TIPN) in a phase II trial ...

Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% ...